Sapir Alex
Related Filers (3)
- PhaseBio Pharmaceuticals Inc (6)
- Dova Pharmaceuticals, Inc. (4)
- Fulcrum Therapeutics, Inc. (1)
- Show More ...
Ownership (11)
3
Monday, 7/3/2023
Fulcrum Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 5/19/2023
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Friday, 6/4/2021
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Friday, 6/5/2020
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
3
Friday, 2/14/2020
PhaseBio Pharmaceuticals Inc: Initial statement of beneficial ownership of securities
4
Friday, 2/14/2020
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/15/2018
Dova Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/27/2017
Dova Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/7/2017
Dova Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/28/2017
Dova Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities